Legislation to make drug makers reveal how much they spend marketing high-priced drugs has stalled in the Virginia General Assembly, at least for this year. Virginia state senators said the bill wasn’t ready for prime time, but was an issue …
from News – Insurance Journal
没有评论:
发表评论